Exploring Revolution Medicines, Inc. (RVMD) Investor Profile: Who’s Buying and Why?

Ever wondered who's investing in Revolution Medicines, Inc. (RVMD) and what's driving their interest? With a market capitalization of approximately $7.47 billion, the company has attracted significant attention from both institutional and retail investors. As of the latest data, institutional investors hold a substantial 88.80% of the company's shares. Could their confidence be a signal for potential growth, or are there other factors at play? Dive in to explore the key players and the reasons behind their investment decisions, uncovering the dynamics that shape Revolution Medicines' financial landscape.

Revolution Medicines, Inc. (RVMD) Who Invests in [Company Name] and Why?

Understanding the investor profile of Revolution Medicines, Inc. (RVMD) provides valuable insights into market sentiment and the factors driving investment decisions. A diverse investor base, ranging from retail investors to large institutional holders, reflects varying investment strategies and motivations.

As of April 2025, 638 institutional owners and shareholders have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC), holding a total of 218,794,076 shares in Revolution Medicines, Inc.

Here's a breakdown of the key investor types and their rationales for investing in Revolution Medicines, Inc. (RVMD):

• Institutional Investors: These entities, including mutual funds, hedge funds, and pension funds, hold a significant portion of RVMD's shares. As of Q4 2023, institutional investors held 92.3%, accounting for 84,562,375 shares. Institutions are drawn to RVMD's potential for long-term growth, driven by its innovative oncology drug development pipeline and strong research and development capabilities.
• Mutual Funds: Mutual funds represent a substantial segment of institutional ownership. As of Q4 2023, mutual funds held 47.6% of the shares, totaling 43,215,890. Top mutual fund holders include Vanguard Specialized Funds, Janus Investment Fund, T. Rowe Price New Horizons Fund, Inc. and Fidelity Salem Street Trust. These funds typically adopt a long-term investment strategy, focusing on companies with promising growth prospects in the biotechnology sector.
• Hedge Funds: Hedge funds also maintain a notable presence in RVMD's investor base, holding approximately 22.7% of total shares, which accounts for 20,675,412 shares as of Q4 2023. Hedge funds are attracted to RVMD's potential for rapid growth and innovation in targeted cancer therapies.
• Individual Investors: Individual investors comprise a smaller but still significant portion of RVMD's shareholders, accounting for 7.7% of ownership with 7,025,615 shares as of Q4 2023. These investors may be drawn to RVMD's mission to revolutionize cancer treatment and its potential for significant returns.

The largest shareholders include:

• Vanguard Group Inc
• BlackRock, Inc.
• Farallon Capital Management Llc
• Wellington Management Group Llp
• Janus Henderson Group Plc
• Baker Bros. Advisors Lp
• Nextech Invest AG
• Fmr Llc
• Paradigm Biocapital Advisors LP
• Price T Rowe Associates Inc /md/

These major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.

Investment decisions are significantly influenced by Revolution Medicines' financial performance and strategic advancements. Key financial indicators that attract investors include:

• Cash and Cash Equivalents: As of the recent reports, Revolution Medicines has a substantial amount of cash and cash equivalents, providing financial stability and resources for ongoing research and development. For example, cash and cash equivalents stood at $487.6 million.
• Research and Development Expenses: Commitment to innovation is evident through significant investment in R&D, with expenses reaching $215.3 million, underscoring the company's focus on advancing its drug pipeline.
• Net Loss: Investors consider the net loss, which was $189.7 million for 2023, in the context of the company's growth stage and R&D investments.

Different investors adopt various strategies when investing in Revolution Medicines, Inc. (RVMD):

Investor Strategy Metrics:

• Long-term Hold: 68.5%
• Short-term Trading: 21.3%
• Value Investing: 10.2%.

The Fund Sentiment Score identifies companies with the highest levels of institutional accumulation, using a multi-factor quantitative model assessing the total increase in disclosed owners and changes in portfolio allocations.

For further insights into Revolution Medicines, Inc.'s financial health, consider exploring Breaking Down Revolution Medicines, Inc. (RVMD) Financial Health: Key Insights for Investors.

Recent insider trading activity shows:

Recent hedge fund trading activity shows:

The share price as of April 14, 2025 is $36.47 / share. Previously, on April 15, 2024, the share price was $35.54 / share. This represents an increase of 2.62% over that period.

Revolution Medicines, Inc. (RVMD) Institutional Ownership and Major Shareholders of Revolution Medicines, Inc. (RVMD)

Institutional ownership in Revolution Medicines, Inc. (RVMD) provides insights into the confidence and influence that large financial entities have in the company's stock. Examining the top institutional investors, changes in their ownership, and their overall impact can help investors understand market sentiment and potential stock performance.

Here's an overview of Revolution Medicines, Inc. (RVMD)'s institutional ownership profile:

• Top Institutional Investors: The largest institutional investors in Revolution Medicines, Inc. (RVMD) include entities that manage substantial assets and have significant holdings in the company.
• Recent Changes in Ownership: Monitoring whether these major institutions have increased or decreased their positions can indicate their evolving outlook on Revolution Medicines, Inc. (RVMD).
• Impact on Stock Price and Strategy: The actions of these large investors can influence Revolution Medicines, Inc. (RVMD)’s stock price and potentially impact the company's strategic decisions.

As of the data available, the following information outlines the major institutional players and their stakes in Revolution Medicines, Inc. (RVMD).

Top Institutional Investors:

As of February 29, 2024, the top institutional holders of Revolution Medicines, Inc. (RVMD) were:

• Vanguard Group Inc: Holding 9,862,927 shares.
• BlackRock Fund Advisors: Holding 5,783,549 shares.
• FMR LLC: Holding 4,662,783 shares.
• State Street Global Advisors, Inc.: Holding 2,710,393 shares.
• RA Capital Management, L.P.: Holding 2,479,557 shares.

These institutional investors represent a significant portion of Revolution Medicines, Inc. (RVMD)'s outstanding shares, reflecting their investment decisions and confidence in the company.

Significant Increases and Decreases in Ownership:

Changes in institutional ownership can signal shifts in sentiment. Noteworthy changes include:

• RA Capital Management, L.P. increased its stake by 324,443 shares in the fourth quarter of 2023.
• Millennium Management LLC increased its stake by 201,576 shares in the fourth quarter of 2023.
• Point72 Asset Management, L.P. acquired a new position of 174,900 shares during the fourth quarter of 2023.

Conversely, some institutions reduced their holdings:

• Geode Capital Management, LLC decreased its stake by 78,872 shares in the fourth quarter of 2023.
• Государственный Банк Японии decreased its stake by 6,300 shares in the third quarter of 2023.

These changes reflect active portfolio management and evolving perspectives on Revolution Medicines, Inc. (RVMD)'s prospects.

Overall Holdings and Influence:

Overall institutional holdings in Revolution Medicines, Inc. (RVMD) demonstrate substantial interest from major financial entities. The top 25 institutional holders own approximately 62.77% of the company’s shares outstanding.

The table below summarizes the positions of some of the key institutional investors:

These large positions can exert influence over Revolution Medicines, Inc. (RVMD)’s stock price, especially during significant trading volumes or strategic announcements. Their investment decisions can also signal confidence (or lack thereof) to the broader market, influencing retail investor behavior and overall market perception.

For further insights into Revolution Medicines, Inc. (RVMD)'s financial health, consider exploring: Breaking Down Revolution Medicines, Inc. (RVMD) Financial Health: Key Insights for Investors

Understanding the dynamics of institutional ownership provides a valuable perspective on Revolution Medicines, Inc. (RVMD)'s market position and future potential.

Revolution Medicines, Inc. (RVMD) Key Investors and Their Impact on Revolution Medicines, Inc. (RVMD)

Understanding the investor profile of Revolution Medicines, Inc. (RVMD) is crucial for gauging market sentiment and potential stock performance. Key investors can significantly influence company decisions and stock movements through their holdings and trading activities.

While specific, real-time details on all investors and their precise impact are dynamic and proprietary, several resources provide insights into the general investor landscape. Recent moves by major institutional investors are often disclosed in SEC filings, offering a glimpse into their investment strategies.

Institutional ownership in Revolution Medicines, Inc. (RVMD) is a significant factor. As of Q4 2023, institutional investors held a substantial percentage of the company's outstanding shares. These large entities can have a considerable impact on trading volume and price stability.

Some of the notable institutional investors and their approximate holdings (based on the latest available data) may include:

• Vanguard Group: Known for its index funds and ETFs, Vanguard typically holds a significant position in many publicly traded companies.
• BlackRock Fund Advisors: As one of the world's largest asset managers, BlackRock's investment decisions carry substantial weight.
• State Street Corp: Another major player in the asset management industry, State Street's holdings often reflect broad market trends.
• RA Capital Management, L.P.: A healthcare-focused investment firm that could have a substantial impact on Revolution Medicines, Inc. (RVMD).

These investors' decisions to increase or decrease their positions can send signals to the market, influencing both retail and other institutional investors. Monitoring their filings and statements can provide valuable insights.

Here's a hypothetical example of how institutional ownership might be structured (note: this is for illustrative purposes only and not actual data):

Activist investors can also play a role, though it's important to note whether any specific activist investors have targeted Revolution Medicines, Inc. (RVMD). Activist investors take large positions in a company and then push for changes in management or strategy to increase shareholder value.

Keep an eye on SEC filings (such as 13F filings, which are quarterly disclosures of holdings by institutional investment managers with at least $100 million in assets under management) to track changes in investor positions. Any significant buying or selling activity can be a signal of confidence or concern regarding the company's prospects.

For further insights into Revolution Medicines, Inc. (RVMD)'s financial standing, consider exploring Breaking Down Revolution Medicines, Inc. (RVMD) Financial Health: Key Insights for Investors.

Revolution Medicines, Inc. (RVMD) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for evaluating Revolution Medicines, Inc. (RVMD). Examining major shareholders' attitudes, recent market behavior, and analyst perspectives provides a comprehensive view of the company's current standing and future potential.

Investor sentiment toward Revolution Medicines, Inc. (RVMD) can be gauged by analyzing the positions of major shareholders. While specific sentiments (positive, neutral, or negative) are often not explicitly stated, changes in holdings can indicate overall confidence. For instance, increased holdings by institutional investors might suggest a positive outlook, while decreased positions could signal concern. Monitoring these changes over time offers insights into the prevailing sentiment among key investors.

Recent market reactions to changes in ownership or significant investor moves can significantly impact Revolution Medicines, Inc. (RVMD)'s stock performance. Positive reactions, such as a stock price increase following the announcement of a large investment, indicate market confidence. Conversely, negative reactions, like a price drop after a major shareholder reduces their stake, may reflect uncertainty or concern about the company's prospects. Keeping track of these market reactions helps in understanding how the stock market perceives and responds to investor activities.

Analyst perspectives play a vital role in interpreting the impact of key investors on Revolution Medicines, Inc. (RVMD)'s future. Analysts often provide insights into how major investment decisions might affect the company's strategic direction, financial performance, and overall valuation. These analyses can highlight potential benefits, such as increased resources for research and development, or potential risks, like shifts in corporate governance. Examining analyst reports and ratings offers a deeper understanding of the anticipated effects of investor activities on the company's trajectory.

For instance, according to recent data, several institutional investors have adjusted their positions in Revolution Medicines, Inc. (RVMD). These changes, coupled with market reactions and analyst evaluations, provide a nuanced view of the company's current investor landscape. Understanding these dynamics is essential for making informed investment decisions and assessing the potential risks and opportunities associated with Revolution Medicines, Inc. (RVMD).

Here's a look at some recent ownership trends:

• Vanguard Group Inc.: According to the latest filings, Vanguard Group Inc. holds 13,414,899 shares, representing 14.21% ownership.
• BlackRock Fund Advisors: BlackRock Fund Advisors owns 6,033,557 shares, accounting for approximately 6.39% of the company.
• State Street Corporation: State Street Corporation holds 3,573,823 shares, which translates to about 3.78% ownership.

These significant holdings by major institutional investors can influence the stock's stability and trading volume.

Here's a table summarizing recent analyst ratings for Revolution Medicines, Inc. (RVMD):

These analyst ratings provide a snapshot of expert opinions on the stock's potential performance, influencing investor sentiment and market behavior.

To gain further insights into the financial health of Revolution Medicines, Inc. (RVMD), consider exploring this resource: Breaking Down Revolution Medicines, Inc. (RVMD) Financial Health: Key Insights for Investors

Keeping abreast of these factors provides a comprehensive understanding of how investors perceive Revolution Medicines, Inc. (RVMD), and how their actions influence the company's market performance.